Targeted delivery systems leverage the unique properties of nanoparticles to deliver drugs precisely where they are needed. Surface modification techniques allow nanoparticles to be functionalized with specific ligands or antibodies that recognize and bind to clot-specific markers. This ensures that the antithrombotic agents are released in the vicinity of the clot, enhancing the therapeutic effect while reducing potential side effects.
